Atlas Trials

Study to Evaluate the Effects of MBX-8025 in Patients With HoFH

Clinical trial NCT02472535 · COMPLETED

Trial details

NCT number
NCT02472535
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Homozygous Familial Hypercholesterolemia
Start date
2015-04-01
Primary completion
2016-02-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.